Susan Clement Davies
Director/Board Member at SCANCELL HOLDINGS PLC
Susan Clement Davies active positions
Companies | Position | Start | End |
---|---|---|---|
SCANCELL HOLDINGS PLC | Director/Board Member | 2020-09-23 | - |
SCIENCE GROUP PLC | Director/Board Member | 2022-05-17 | - |
Independent Dir/Board Member | 2022-05-17 | - | |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Director/Board Member | 2021-12-31 | - |
Independent Dir/Board Member | 2021-12-31 | - | |
Exploristics Ltd. | Director/Board Member | - | - |
Career history of Susan Clement Davies
Former positions of Susan Clement Davies
Companies | Position | Start | End |
---|---|---|---|
THERACRYF PLC | Director/Board Member | 2018-10-31 | 2023-12-30 |
Independent Dir/Board Member | 2018-10-31 | 2023-12-30 | |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Corporate Officer/Principal | - | 2017-12-31 |
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Corporate Officer/Principal | - | 2017-12-31 |
Training of Susan Clement Davies
London School of Economics & Political Science | Graduate Degree |
University College London | Undergraduate Degree |
Statistics
International
United Kingdom | 9 |
United States | 2 |
Operational
Director/Board Member | 5 |
Independent Dir/Board Member | 3 |
Corporate Officer/Principal | 2 |
Sectoral
Finance | 3 |
Consumer Services | 3 |
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 3 |
---|---|
THERACRYF PLC | Health Services |
SCIENCE GROUP PLC | Commercial Services |
SCANCELL HOLDINGS PLC | Health Technology |
Private companies | 4 |
---|---|
Citigroup Global Markets Ltd.
Citigroup Global Markets Ltd. Investment Banks/BrokersFinance Citigroup Global Markets Ltd. (CGML) is an international broker-dealer firm headquartered in London, UK. The firm was founded in 1983 and is a subsidiary of Citigroup Global Markets Holdings Bahamas Ltd., ultimately held by Citigroup, Inc. (NYSE: C) in the US. CGML has a major presence in the international financial markets as a dealer, market-maker and underwriter in equity and fixed income securities and offers risk-based solutions to producers and investors in commodity markets. They also provide corporate finance services to a wide range of corporate, institutional and government clients. Their trading activities encompass cash, exchange traded and OTC derivative markets. | Finance |
Torreya Partners LLC
Torreya Partners LLC Investment ManagersFinance Torreya Partners LLC engages in provision of financial advisory services. The company was founded by Tim Opler and Mark Simon in 2007 and is headquartered in New York, NY. | Finance |
Exploristics Ltd. | |
MiNA Therapeutics Ltd.
MiNA Therapeutics Ltd. BiotechnologyHealth Technology MiNA Therapeutics Ltd. develops RNA activation therapeutics. The firm's saRNA platform enables the development of new medicines that restore normal function to patients? cells. It applies technology and clinical know-how to transform the therapy landscape of cancer and other severe diseases. The company was founded by John J. Rossi, Nagy Habib and Pal Saetrom in 2008 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Susan Clement Davies
- Experience